久其軟件(002279.SZ):公司有專業團隊對大數據、人工智能等前沿技術進行跟蹤研究
格隆匯4月28日丨有投資者在投資者互動平台向久其軟件(002279.SZ)提問,“公司在數字經濟,人工智能,大數據這3個方面具體有哪些?是否有進一步佈局”
久其軟件回覆稱,在當前數字經濟大時代背景下,公司一方面聚焦“數字政府”建設,全力耕耘於政府決策科學化、社會治理精準化、公共服務高效化建設;另一方面在企業集團管控領域,公司圍繞“數據+智能”,引領企業的數字化轉型。人工智能與大數據方面,公司有專業團隊對大數據、人工智能等前沿技術進行跟蹤研究,並圍繞客户的應用場景利用新技術進行賦能注智。未來公司會持續關注行業內新技術發展,為數字經濟的高質量發展賦能。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.